Member access

4-Traders Homepage  >  Shares  >  Nasdaq  >  Genomic Health, Inc.    GHDX   US37244C1018

SummaryQuotesChart AnalysisNewsCalendarCompanyFinancialsConsensusRevisionsForum 
Income Statement Evolution
Genomic Health, Inc. : Income Statement Evolution
Annual Income Statement Data
Actuals in M $ Estimates in M $
Fiscal Period December 201020112012201320142015
Sales178206235262298341
Operating income (EBITDA)11,115,613,97,4215,923,7
Operating profit (EBIT)3,928,268,43-1,358,3023,4
Pre-Tax Profit (EBT)--8,67---
Net income4,297,858,25-1,028,8727,6
EPS ( $)0,140,260,26-0,020,340,77
Dividend per Share ( $)------
Yield------
Announcement Date02/08/2011
09:00pm
02/06/2012
09:01pm
02/06/2013
09:01pm
---
Finances - Leverage
Genomic Health, Inc. : Finances - Leverage
Actuals in M $ Estimates in M $
Fiscal Period December 201020112012201320142015
Debt------
Finance-10099,171,397,5133
Operating income (EBITDA)11,115,613,97,4215,923,7
Leverage
(Debt/EBITDA)
------
Capital Expenditure4,446,189,8514,111,5-
Book Value Per Share (BVPS)-3,88 $4,22 $4,35 $5,05 $6,41 $
Cash Flow per Share-0,73 $0,81 $0,75 $0,95 $0,52 $
Announcement Date02/08/2011
09:00pm
02/06/2012
09:01pm
02/06/2013
09:01pm
---
Balance Sheet Analysis
Genomic Health, Inc. : Balance Sheet Analysis
Assessed data source :
© 2013 Thomson Reuters
Advertisement
Financial Ratios

Size 2013e 2014e
Capitalization 1 124 M$ -
Company Value 1 053 M$ 1 027 M$
Valuation 2013e 2014e
PER (Price / EPS) 111x
Capitalization / Revenue 4,29x 3,78x
EV / Revenue 4,02x 3,45x
EV / EBITDA 142x 64,6x
Yield (DPS / Price) - -
Profitability 2013e 2014e
Operating Margin (EBIT / Sales) -0,52% 2,79%
operating laverage (Delta EBIT / Delta Sales) - #
Net Margin (Net Profit / Revenue) -0,39% 2,98%
ROA (Net Profit / Asset) -0,69% 3,70%
ROE (Net Profit / Equities) -0,51% 3,35%
Rate of Dividend - -
Balance Sheet Analysis 2013e 2014e
CAPEX / Sales   5,38% 3,87%
Cash Flow / Sales (Taux d'autofinancement) 8,65% 9,66%
Capital Intensity (Assets / Sales) 0,57x 0,81x
Financial Leverage (Net Debt / EBITDA) -9,61x -6,13x
Price Earning Ratio
Genomic Health, Inc. : Price Earning Ratio
EPS & Dividend
Genomic Health, Inc. : EPS Dividend
Dynamic quotes  
ON
| OFF
Copyright © 2013 Surperformance. All rights reserved.